

UK pharma group Shire topped the FTSE 100 on Friday morning after the US drug regulator said it will fast-track the company's application for its 'Lif...


** Shire easily top FTSE 100 gainer & within reach of an all-time high ** Follows gains in US shares after FDA gave its dry eye drug priority review s...




** Shire's U.S. shares up in afternoon trading, reversing course after FDA gives its dry eye drug priority review status ** Stock up nearly 4 pct at $...

